Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × Lutetium-177 × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 5 Neuroendocrine Tumors 2 Gastro-enteropancreatic neuroendocrine tumor 2 Urogenital Neoplasms 1 Prostatic Diseases 1 Pheochromocytoma 1 Paraganglioma 1 Oligometastatic Prostate Cancer (OMPC) 1 Neoplasm Metastasis 1 Metastatic Neuroendocrine Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer (mCRPC) 1 Carcinoma, Merkel Cell 1 Carcinoma 1 Advanced Gastroenteropancreatic Neuroendocrine Tumor 1

Interventions

Rituximab 21 Cyclophosphamide 11 Lenalidomide 9 zanubrutinib 7 venetoclax 6 orelabrutinib 6 obinutuzumab 6 fludarabine 6 pirtobrutinib 4 fludarabine phosphate 4 Vincristine 4 Prednisone 4 Magnetic Resonance Spectroscopy 4 CT-P10 4 Bendamustine Hydrochloride 4 ibrutinib 3 Whole-Body Irradiation 3 Specimen Handling 3 Doxorubicin 3 acalabrutinib 2 Radiation 2 Mycophenolic Acid 2 Maintenance 2 Cyclosporine 2 Biopsy 2 voruciclib 1 umbralisib 1 treosulfan 1 tislelizumab 1 tafasitamab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡